• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHAO Hui,ZHAO Wei,LI Suxia.Study on the mechanism of paeonol delaying airway remodeling in asthma based on TLR4/NF-κB pathway[J].Journal Of Pharmaceutical Research,2024,43(11):1067-1071[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2520times   Download 2209次 QR Code for this article
Scan with your phone!
基于TLR4/NF-κB通路研究丹皮酚延缓气道重塑治疗哮喘的作用机制
赵辉1,赵伟2,李素霞1
Font:Larger+|Default|Smaller-
(1.菏泽医学专科学校,山东 菏泽 274000)
摘要:
目的 基于Toll样受体4/核转录因子-κB(TLR4 / NF-κB)信号通路,研究丹皮酚对哮喘大鼠气道重塑的影响,探讨其治疗哮喘的可能机制。方法 随机将SD大鼠分为正常对照组、哮喘模型组、地塞米松组和丹皮酚低剂量组(75 mg·kg-1)、中剂量组(150 mg·kg-1)、高剂量组(300 mg·kg-1)。采用卵白蛋白(OVA)致敏法制备哮喘大鼠模型,治疗组采用雾化吸入给药。采用HE染色检测肺组织病理形态改变;采用计算机图象分析肺组织气道壁厚度;采用免疫组织化学法检测大鼠肺组织中NF-κB蛋白的表达;采用RT-PCR法检测大鼠肺组织中TLR4 mRNA的表达。结果 与正常对照组比较,哮喘模型组大鼠出现严重的病理损伤和气道重塑,气道壁厚度、WAi/Pbm、WAt/Pbm和WAm/Pbm、肺组织中TLR4及NF-κB表达显著升高(P<0.05)。经地塞米松和丹皮酚雾化吸入治疗后,各组大鼠气道壁厚度、WAi/Pbm、WAt/Pbm和WAm/Pbm、肺组织中TLR4及NF-κB表达明显降低(P<0.05),且呈现剂量依赖性。结论 丹皮酚可有效改善哮喘大鼠气道重塑,其机制可能与抑制哮喘大鼠肺组织中TLR4 / NF-κB信号通路有关。
关键词:  丹皮酚  气道重塑  Toll样受体4  核转录因子-κB
DOI:10.13506/j.cnki.jpr.2024.11.005
基金项目:
Publication Date:November 25, 2024
Study on the mechanism of paeonol delaying airway remodeling in asthma based on TLR4/NF-κB pathway
ZHAO Hui1,ZHAO Wei2,LI Suxia1
(1.Heze Medical College,Heze 274000,China;2. Shandong Provincial Hospital Heze Hospital,Heze 274013,China)
Abstract:
Objective To investigate the mechanism of paeonol delaying airway remodeling in asthma based on TLR4/NF-κB signaling pathway,to explore the possible mechanism of paeonol in treating asthma. Methods Sprague-dawley rats were randomly divided into normal control group,asthma model group,dexamethasone group,low-dose paeonol group(75 mg·kg-1),middle-dose paeonol group(150 mg·kg-1)and high-dose paeonol group(300 mg·kg-1). The asthma rat model was established by ovalbumin(OVA)sensitization. The treatment group was treated by aerosol inhalation. The pathological changes of lung tissue were detected by HE staining;the thickness of airway wall was analyzed by computer image analysis;the expression of NF-κB protein was detected by immunohistochemistry,the expression of TLR4 mRNA was detected by RT-PCR. Results Compared with the normal control group,the asthmatic model group showed severe pathological injury and airway remodeling,the airway wall thickness,WAi/Pbm、WAt/Pbm and WAm/Pbm、the expression of TLR4 and NF-κB in lung tissue were significantly increased(P<0.05). After treated with artesunate and paeonol,the airway wall thickness,WAi/Pbm、WAt/Pbm and WAm/Pbm、the expression of TLR4 and NF-κB in lung tissue were significantly decreased(P<0.05). Conclusion Paeonol can effectively improve airway remodeling in asthmatic rats,and the mechanism may be related to the inhibition of TLR4/NF-κB signaling pathway in the lung tissue of asthmatic rats.
Key words:  Paeonol  Airway remodeling  Toll-like receptor 4  Nuclear factor-κB
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.